本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Propanc Biopharma, Inc.

1.98
-0.5300-21.12%
盘后2.040.0600+3.03%19:59 EDT
成交量:53.39万
成交额:118.29万
市值:2,497.14万
市盈率:-0.04
高:2.55
开:2.50
低:1.93
收:2.51
52周最高:30.00
52周最低:0.0002
股本:1,261.18万
流通股本:340.45万
量比:1.27
换手率:15.68%
股息:- -
股息率:- -
每股收益(TTM):-51.7796
每股收益(LYR):-1.7983
净资产收益率:-767.20%
总资产收益率:-298.55%
市净率:1.38
市盈率(LYR):-1.10

数据加载中...

2025/08/19

重要事件披露

Form 8-K - Current report
2025/08/13

重要事件披露

Form 8-K - Current report
2025/07/30

重要事件披露

Form 8-K - Current report
2025/07/28

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/07/22

重要事件披露

Form 8-K - Current report
2025/06/27

重要事件披露

Form 8-K - Current report
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/30

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/08

重要事件披露

Form 8-K - Current report
2025/04/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/21

重要事件披露

Form 8-K - Current report
2025/04/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/04/02

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/31

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/03/18

重要事件披露

Form 8-K - Current report
2025/02/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/12

重要事件披露

Form 8-K - Current report
2024/12/20

重要事件披露

Form 8-K - Current report